Investors have definitely seen some solid trading in Myriad Genetics, Inc. (MYGN) lately, leading to gains for some. However, MYGN is now in overbought territory thanks to its latest move, as the firm has an RSI value of 77.1. Additionally, Myriad Genetics currently has a Zacks Rank #4 (Sell), so if the earnings estimate trend is any guide, a fall might be coming for this overbought stock.
MYRIAD GENETICS INC (MYGN): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies
- Myriad Genetics